1.Sonographic Diagnosis of Cervical Lymph Node Metastasis in Patients with Thyroid Cancer and Comparison of European and Korean Guidelines for Stratifying the Risk of Malignant Lymph Node
Sae Rom CHUNG ; Jung Hwan BAEK ; Yun Hwa RHO ; Young Jun CHOI ; Tae-Yon SUNG ; Dong Eun SONG ; Tae Yong KIM ; Jeong Hyun LEE
Korean Journal of Radiology 2022;23(11):1102-1111
Objective:
To evaluate the ultrasonography (US) features for diagnosing metastasis in cervical lymph nodes (LNs) in patients with thyroid cancer and compare the US classification of risk of LN metastasis between European and Korean guidelines.
Materials and Methods:
From January 2014 to December 2018, US-guided fine-needle aspiration was performed on 836 LNs from 714 patients for the preoperative nodal staging of thyroid cancer. The US features of LNs were retrospectively reviewed for the following features: size, presence of hilum, margin, orientation, cystic change, punctate echogenic foci (PEF), large echogenic foci, eccentric cortical thickening, abnormal vascularity, and cortical hyperechogenicity. A multiple logistic regression analysis was performed to identify the independent US features for the diagnosis of metastatic LNs. The diagnostic performance of independent US features was subsequently evaluated. LNs were categorized according to the Korean Thyroid Imaging Reporting and Data System (K-TIRADS) and European Thyroid Association (ETA) guidelines, and the correlation between the two sets of classifications was assessed.
Results:
Absence of the hilum, presence of cystic changes, PEF, abnormal vascularity, and cortical hyperechogenicity were independent US features of metastatic LNs. Cystic changes, PEF, abnormal vascularity, and cortical hyperechogenicity showed high specificity (86.8%–99.6%). The absence of the hilum had the highest sensitivity yet low specificity (66.4%). When LNs were classified according to the ETA guidelines and K-TIRADS, they yielded similar categorizations of malignancy risks and were strongly correlated (Spearman coefficient, 0.9766 [95% confidence interval, 0.973–0.979]). According to the ETA guidelines, 9.8% (82/836) of LNs were classified as “not specified.”
Conclusion
Absence of hilum, cystic changes, PEF, abnormal vascularity, and cortical hyperechogenicity were independent US features suggestive of metastatic LNs in thyroid cancer. Both K-TIRADS and the ETA guidelines provided similar risk stratification for metastatic LNs with a high correlation; however, the ETA guidelines failed to classify 9.8% of LNs into a specific risk stratum. These results may provide a basis for revising LN classification in future guidelines.
2.Clinical comparisons of laparoscopically assisted vaginal hysterectomy and total vaginal hysterectomy.
Sam Yong SHIM ; Yun Seok YANG ; Young Rae SONG ; Sang Hun JUN ; Ki Hwan KIM ; Kyung Hwa KANG ; Byung Kwan LEE ; Jeong Hoon RHO ; Kwan Young OH ; In Taek HWANG ; Ji Hak JEONG ; Joon Suk PARK
Korean Journal of Obstetrics and Gynecology 2006;49(1):147-156
OBJECTIVE: To compare the clinical results between laparoscopically assisted vaginal hysterectomy (LAVH) and total vaginal hysterectomy (TVH). METHODS: We reviewed the medical records of patients who underwent LAVH and TVH from January 2002 to December 2004 in 00 university hospital without the history of uterine prolapse or pelvic relaxation. We evaluated age, parity, previous abdominal operations, indication of hysterectomy, size of the uterus, operation time, hemoglobin change, hospital day, the degree of postoperative pain and initiation of diet and postoperative complications. RESULTS: The age and parity of the patients in both groups were not different statistically. There were history of previous abdominal operations in 20.8% of LAVH group and 25.3% of TVH group which didn't have statistic significance. Major indications of the operation were uterine myomas in both groups. The average weight of the extracted uterus were 272.9+/-114.5 gm and 225.6+/-87.0 gm in the LAVH group and the TVH group respectively which had significance, and the operation time were 81.1+/-23.4 minutes and 71.1+/-37.8 minutes respectively which had significance. There were no difference in the hemoglobin drop of the postoperative day 1, but the hemoglobin drop of the postoperative day 4 was larger in the LAVH group. Postoperative complications occurred more often in the TVH group (15.2%) than LAVH group (11.9%) but didn't have significance, and the complications were treated by conservative managements and observation of the progress. And also the hospital day, the degree of postoperative pain and initiation of diet had no significance. CONCLUSION: Both LAVH and TVH had no statistic difference in the postoperative morbidity and recuperation. Moreover the indications of operation for both surgeries had no statistic difference, but LAVH had a preference for the larger size of uterus. Furthermore in order to increase the satisfactions of patients and remedy the weak points of procedures, research on the indications and contra-indications between the operative approaches and training on the operative procedures are required.
Diet
;
Female
;
Humans
;
Hysterectomy
;
Hysterectomy, Vaginal*
;
Leiomyoma
;
Medical Records
;
Pain, Postoperative
;
Parity
;
Postoperative Complications
;
Relaxation
;
Surgical Procedures, Operative
;
Uterine Prolapse
;
Uterus
3.Analysis of the Nursing Interventions done by MICU and SICU nurses using NIC.
Eun Jung RYU ; Kyung Sook CHOI ; Young Mi KWON ; Suk Nam JOO ; Suk Rae YUN ; Hwa Sook CHOI ; Seoung Bok KWON ; Jeong Hee LEE ; Bok Ja KIM ; Hyung Yae KIM ; Ok Hee AHN ; Eun Sun RHO ; Kyung Sook PARK
Journal of Korean Academy of Nursing 1998;28(2):457-467
The purpose of this research was to identify nursing interventions performed by MICU and SICU nurses. For data collection this study used the taxonomy of the Nursing Interventions Classification(NIC: 433 nursing interventions) which was modified by McCloskey and Bulecheck(1996). Each of the 433 interventions were identified as used by MICU and SICU nurses. More than 50% of the ICU nurses performed 280 nursing interventions at least monthly. Rarely used interventions included 26 nursing interventions in the childbearing care class. Overall, both MICU and SICU nurses used interventions in the Physicological : Complex domain most often on a daily basis and the interventions in the Family domain least often. The most frequently reported interventions as being used daily in the MICU were chest physioterapy, airway suctioning and coughing enhancement and, in the SICU, documentation and airway suctioning. There were significant differences between MICU and SICU nurses differences interventions childbearing care, cognitive therapy, communication enhancement, coping assistance, elimination management, lifespan care, health system mediation, immobility management, medication management, neurologic management, patient education psychological comfort promotion, physical comfort program, respiratory management, risk management and information management. The SICU nurses performed there interventions more frequently than the MICU nurses. These findings will help in building of a standardized language for the MICU and SICU and enhance the quality of nursing care.
Classification
;
Cognitive Therapy
;
Cough
;
Surveys and Questionnaires
;
Delivery of Health Care
;
Humans
;
Information Management
;
Negotiating
;
Nursing Care
;
Nursing*
;
Patient Education as Topic
;
Risk Management
;
Suction
;
Thorax
4.The anti-inflammatory effect of Cheongseoikki-tang ethanol extract on allergic reactions mediated by bone marrow-derived mast cells.
Joon-Ho KEUM ; Ok-Hwa KANG ; Sung-Bae KIM ; Su-Hyun MUN ; Yun-Soo SEO ; Ma-Ryong KIM ; Jung-Rae RHO ; Young-Seob LEE ; Chung-Berm PARK ; Young-Guk KIM ; Yong-Il KIM ; Sin-Hee HAN ; Dong-Yeul KWON
Chinese journal of integrative medicine 2013;19(5):380-386
OBJECTIVECheongseoikki-tang (CIT, Korean), also called Qingshu Yiqi decoction () and Seisho-ekki-to (Japanese), is well known as an effective traditional combination of herbs for treating cardiovascular diseases. This study was to research its effects on bone marrow-derived mast cell (BMMC)-mediated allergy and inflammation mechanisms.
METHODSIn this study, the biological effect of Cheongseoikki-tang ethanol extract (CITE) was evaluated, focusing on its effects on the production of allergic mediators by phorbol 12-myristate 13-acetate (PMA) plus calcium ionophore A23187 (A23187)-stimulated BMMCs. These allergic mediators included interleukin-6 (IL-6), prostaglandin D2 (PGD2), leukotriene C4 (LTC4), and β-hexosaminidase (β-hex).
RESULTSOur data revealed that CITE inhibited the production of IL-6, PGD2, LTC4, and β-hex induced by PMA plus A23187 (P<0.05).
CONCLUSIONThese findings indicate that CITE has the potential for use in the treatment of allergy.
Animals ; Anti-Inflammatory Agents ; pharmacology ; therapeutic use ; Bone Marrow Cells ; pathology ; Calcimycin ; pharmacology ; Cell Degranulation ; drug effects ; Cell Survival ; drug effects ; Drugs, Chinese Herbal ; pharmacology ; therapeutic use ; Hypersensitivity ; drug therapy ; pathology ; Interleukin-6 ; secretion ; Leukotriene C4 ; pharmacology ; Male ; Mast Cells ; drug effects ; pathology ; physiology ; Mice ; Mice, Inbred BALB C ; Prostaglandin D2 ; biosynthesis ; Tetradecanoylphorbol Acetate ; pharmacology ; beta-N-Acetylhexosaminidases ; metabolism
5.Korean multicenter clinical trial of simvastatin ( KS-1 study ).
Hyun Ho SHIN ; Kwon Bae KIM ; Jung Chaee KANG ; Min Soo SON ; Jae Hyung KIM ; Jong Seong KIM ; Seung Yun CHO ; Yung Woo SHIN ; Hyo Soo KIM ; In Ho CHAE ; Young Bae PARK ; Sung Choon CHOE ; Jung Don SEO ; Jong Hwa BAE ; Young Moo RHO ; Won Ro LEE ; Shung Chull CHAE ; Kwon Sam KIM ; Jung Chun AHN ; Cheol Ho KIM ; Jeong Euy PARK ; Cheol Whan LEE ; Jin Won JEONG ; Kyung Hoon CHOE ; Gil Ja SHIN ; Kun Joo RHEE ; Jae Ki KO ; Son Pyo HONG ; Un Ho RYOO ; Eun Seok JEON ; Dong Woon KIM ; Chong Yun RIM
Korean Journal of Medicine 1999;57(5):906-915
The aim of this study was to investigate the efficacy of simvastatin to improved lipid profiles in hypercholesterolemic Korean patients. METHODS: From 25 hospitals in Korea, 478 hypercholesterolemic patients were enrolled from November 1996 to April 1998. The inclusion criteria was hypercholesterolemia over 240 mg/dl after diet therapy for 1 month or hypercholesterolemia over 220 mg/dl in patients with definite evidence of ischemic heart disease. Simvastatin 10mg was started and doubled up to 40mg if total cholesterol level remained higher than 200 mg/dl at monthly check. Of 478 subjects, 344 patients in whom study protocol was not violated were analyzed. RESULTS: Male to female ratio was 27:73 and 47% of the subjects were in 6th decade. Hypertension, coronary artery disease, and diabetes mellitus were present in 30, 10, and 4% of the subjects. Baseline lipid profile (mean of total cholesterol-LDL-HDL-triglyceride mg/dl) was 274-185-52-188. The dose of simvastatin for 3 months was 10/10/10mg in 61% of subjects, 10/20/20mg in 21%, 10/10/20mg in 7%, and 10/20/40mg in 12%. The change of total cholesterol level(before-4wk-8wk-12wk-withdrawal 4wk) was 274-209- 205-198-250, and the maximal reduction rate was 27%. The change of LDL-cholesterol was 185-123-116-110-159, with maximal reduction rate 39%. The change of HDL-cholesterol was 52-54-56-55-54, with maximal increase rate 9%. The change of tryglyceride was 188-161- 164-162-189, with maximal reduction rate 15%. The value before/after treatment of ApoA1, ApoB, and Lp(a) was 129/129, 138/83, and 9.3/10.7, respectively. The level of LDL-cholesterol at the end of treatment was below 100mg/dl in 36% of subjects, 100-130 in 45%, 130-160 in 16%, and over 160mg/dl in 4%. The reduction rate of LDL-cholesterol was different between subjects whose LDL decreased below 100 and those whose LDL did not decrease below 130mg/dl, which suggests the existence of the individual difference of responsiveness to simvastatin. There were only 3 subjects (0.9%) who showed increase of liver enzyme over 3 times as the upper normal limit. Conclusion: Simvastatin is effective in improving lipid profiles in hypercholesterolemic Korean patients without serious side effects.
Apolipoproteins B
;
Cholesterol
;
Coronary Artery Disease
;
Diabetes Mellitus
;
Diet Therapy
;
Female
;
Humans
;
Hypercholesterolemia
;
Hypertension
;
Individuality
;
Korea
;
Liver
;
Male
;
Myocardial Ischemia
;
Simvastatin*
6.Korean multicenter clinical trial of simvastatin ( KS-1 study ).
Hyun Ho SHIN ; Kwon Bae KIM ; Jung Chaee KANG ; Min Soo SON ; Jae Hyung KIM ; Jong Seong KIM ; Seung Yun CHO ; Yung Woo SHIN ; Hyo Soo KIM ; In Ho CHAE ; Young Bae PARK ; Sung Choon CHOE ; Jung Don SEO ; Jong Hwa BAE ; Young Moo RHO ; Won Ro LEE ; Shung Chull CHAE ; Kwon Sam KIM ; Jung Chun AHN ; Cheol Ho KIM ; Jeong Euy PARK ; Cheol Whan LEE ; Jin Won JEONG ; Kyung Hoon CHOE ; Gil Ja SHIN ; Kun Joo RHEE ; Jae Ki KO ; Son Pyo HONG ; Un Ho RYOO ; Eun Seok JEON ; Dong Woon KIM ; Chong Yun RIM
Korean Journal of Medicine 1999;57(5):906-915
The aim of this study was to investigate the efficacy of simvastatin to improved lipid profiles in hypercholesterolemic Korean patients. METHODS: From 25 hospitals in Korea, 478 hypercholesterolemic patients were enrolled from November 1996 to April 1998. The inclusion criteria was hypercholesterolemia over 240 mg/dl after diet therapy for 1 month or hypercholesterolemia over 220 mg/dl in patients with definite evidence of ischemic heart disease. Simvastatin 10mg was started and doubled up to 40mg if total cholesterol level remained higher than 200 mg/dl at monthly check. Of 478 subjects, 344 patients in whom study protocol was not violated were analyzed. RESULTS: Male to female ratio was 27:73 and 47% of the subjects were in 6th decade. Hypertension, coronary artery disease, and diabetes mellitus were present in 30, 10, and 4% of the subjects. Baseline lipid profile (mean of total cholesterol-LDL-HDL-triglyceride mg/dl) was 274-185-52-188. The dose of simvastatin for 3 months was 10/10/10mg in 61% of subjects, 10/20/20mg in 21%, 10/10/20mg in 7%, and 10/20/40mg in 12%. The change of total cholesterol level(before-4wk-8wk-12wk-withdrawal 4wk) was 274-209- 205-198-250, and the maximal reduction rate was 27%. The change of LDL-cholesterol was 185-123-116-110-159, with maximal reduction rate 39%. The change of HDL-cholesterol was 52-54-56-55-54, with maximal increase rate 9%. The change of tryglyceride was 188-161- 164-162-189, with maximal reduction rate 15%. The value before/after treatment of ApoA1, ApoB, and Lp(a) was 129/129, 138/83, and 9.3/10.7, respectively. The level of LDL-cholesterol at the end of treatment was below 100mg/dl in 36% of subjects, 100-130 in 45%, 130-160 in 16%, and over 160mg/dl in 4%. The reduction rate of LDL-cholesterol was different between subjects whose LDL decreased below 100 and those whose LDL did not decrease below 130mg/dl, which suggests the existence of the individual difference of responsiveness to simvastatin. There were only 3 subjects (0.9%) who showed increase of liver enzyme over 3 times as the upper normal limit. Conclusion: Simvastatin is effective in improving lipid profiles in hypercholesterolemic Korean patients without serious side effects.
Apolipoproteins B
;
Cholesterol
;
Coronary Artery Disease
;
Diabetes Mellitus
;
Diet Therapy
;
Female
;
Humans
;
Hypercholesterolemia
;
Hypertension
;
Individuality
;
Korea
;
Liver
;
Male
;
Myocardial Ischemia
;
Simvastatin*